 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Cullen Dutmer and Andrew Liu.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.345 |
|
|
|
-
Dutmer CM, Liu AH. Knowledge gaps and future opportunities for biologics in childhood allergic and immunologic disorders. J Allergy Clin Immunol. 2023 03; 151(3):691-693.
Score: 0.915
-
Dutmer CM, Kim H, Searing DA, Zoratti EM, Liu AH. Asthma in inner city children: recent insights: United States. Curr Opin Allergy Clin Immunol. 2018 04; 18(2):139-147.
Score: 0.657
-
Dutmer CM, McGraw MD, Liu AH. Inner-city asthma: special considerations for management. Curr Opin Allergy Clin Immunol. 2016 Apr; 16(2):148-56.
Score: 0.572
-
Liu AH, Anderson WC, Dutmer CM, Searing DA, Szefler SJ. Advances in asthma 2015: Across the lifespan. J Allergy Clin Immunol. 2016 08; 138(2):397-404.
Score: 0.146
-
Jackson DJ, Bacharier LB, Gergen PJ, Gagalis L, Calatroni A, Wellford S, Gill MA, Stokes J, Liu AH, Gruchalla RS, Cohen RT, Makhija M, Khurana Hershey GK, O'Connor GT, Pongracic JA, Sherenian MG, Rivera-Spoljaric K, Zoratti EM, Teach SJ, Kattan M, Dutmer CM, Kim H, Lamm C, Sheehan WJ, Segnitz RM, Dill-McFarland KA, Visness CM, Becker PM, Gern JE, Sorkness CA, Busse WW, Altman MC. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet. 2022 08 13; 400(10351):502-511.
Score: 0.056
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|